About the author

Currently residing in New Zealand and employed in the education industry, Mr. A. Burden holds a M.Com in International Business from the University of Sydney and used these skills together with his passion for investing to establish BioPharmCatalyst in June 2010 as a tool for investing decisions in the US pharmaceutical market. He spends much of his free time mountain biking, playing squash and hiking.

Latest Articles

Dear readers of BioPharmCatalyst, Thank you to all readers who have followed and supported BioPharmCatalyst over the past five years. Yes, that’s correct, BioPharmCatalyst celebrated it’s 5th anniversary earlier this week. BPC is run independently and a change in working circumstances has meant that updating the website has become quite time consuming to maintain over the past […]

Latest updates to the Company Pipeline Database for May 18 and 19, 2015. Refer to the FDA Calendar for upcoming catalysts: In addition, over 100 updates were made over the weekend as companies continued with their reporting season. You can find the updates from last week by clicking the “updated” column on the far right of the Company Pipeline Database. […]